Osteosarcoma - 28 Studies Found
| Completed |
: Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients : Osteosarcoma : 2008-05-27 |
| Not yet recruiting |
: Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma : Osteosarcoma : 2009-10-23 : Radiation: heavy ion radiotherapy (C12) Desired target of |
| Completed |
: Chemotherapy for Patients With Osteosarcoma : Osteosarcoma : 2007-08-29 : Drug: Pemetrexed 500 mg/m^2, IV every 21 days until disease progression, unacceptable toxicity, particip |
| Active, not recruiting |
: A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung : Osteosarcoma : 2008-09-11 :
|
| Completed |
: Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma : Osteosarcoma : 2013-03-06 : Other: laboratory biomarker analysis Correlative studies |
| RECRUITING |
: Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study : Locally Advanced Osteosarcoma : 2024-11-21 : Given IV |
| RECRUITING |
: Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma : Pulmonary Metastatic Osteosarcoma (pOS) : 2024-11-21 : Natalizumab is an FDA approved monotherapy for treatment of relapsing forms of MS.It is also indicated for inducing and maintaining clinical |
| NOT_YET_RECRUITING |
: Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma : Osteosarcoma : 2024-11-21 : Vactosertib is given twice a day, five days on and two days off in four-week cycles.Vactosertib is a transforming growth factor-beta (TGF-?) typ |